2011-2013 Metals in Biology GRC and Bioinorganic GRS
2011-2013 生物GRC和生物无机GRS中的金属
基本信息
- 批准号:8394937
- 负责人:
- 金额:$ 0.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-12-01 至 2013-11-30
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAnabolismAntibioticsBioinorganic ChemistryBiologyChemicalsChemistryCollaborationsCommunitiesDNADataDevelopmentDiagnosticDisciplineDiseaseDrug TargetingEnsureEnzymesFosteringFundingFutureHormonesIonsKnowledge DiscoveryLeukotrienesMalignant NeoplasmsMetalsModelingMolecularNatureNeurotransmittersParentsParkinson DiseaseParticipantPathway interactionsPerformancePhysicsPlayPostdoctoral FellowRequest for ProposalsResearchResearch PersonnelRoleRunningScientistSteroidsStudentsTrainingbiological systemsgraduate studentimprovedlecturesmeetingsmetalloenzymemultidisciplinaryorganizational structurepublic health relevancesuccesssymposiumtool
项目摘要
DESCRIPTION (provided by applicant): This proposal requests funds to support the Metals in Biology Gordon Research Conference (MIB GRC) in Jan-Feb, 2011-2013, and the associated Graduate Research Seminar in Bioinorganic Chemistry (GRS) in February, 2011-2013. The MIB GRC provides the principal forum for the discussion of research at the forefront of bioinorganic chemistry. It is the core meeting for the field, is a 'flagship', leading GRC with an 85% performance rating (2008 data), and is consistently oversubscribed even though it has met consistently since 1962. The GRS was established in 1996 in order to provide a forum for graduate students and postdocs to participate in a meeting that overlaps with the "parent" MIB GRC (for one evening), yet also runs independently. This organizational structure ensures that the students and postdocs interact with leading researchers while developing their own sense of community, providing a means for future leaders of the field to emerge. The two and a half day GRS is organized by young investigators with the support of leading scientists from the associated GRC. A central theme of both meetings is the need to understand the critical role that metal ions play in diverse biological systems. Specifically, metal ions are critical for the function of over one third of all enzymes, and are involved in a number of important biosynthetic pathways including the conversion of electrochemical to chemical energy, and the biosynthesis of antibiotics, DNA, neurotransmitters, steroids, leukotrienes, and hormones. The molecular-level details regarding metalloenzyme function emerge from multiple complementary lines of study, at the interface of chemistry, biology, and physics. A thorough understanding of metallobiochemistry is critical to the development of potential diagnostic tools and drug targets for the treatment of diseases such as Alzheimer's, Parkinson's, and cancer. Discussion of these issues in formal lectures and informal interactions in the unique Gordon Research Conference format effectively disseminates knowledge of discoveries at the forefront of research in the field, fosters collaborations, and improves the cohesiveness of the field, notwithstanding its highly multidisciplinary nature.
描述(由申请人提供):本提案要求资助2011-2013年1-2月生物戈登金属研究会议(MIB GRC)和2011-2013年2月生物无机化学研究生研究研讨会(GRS)。MIB GRC为讨论生物无机化学前沿研究提供了主要论坛。它是该领域的核心会议,是一个“旗舰”,以85%的绩效评级(2008年数据)领先于GRC,并且一直超额认购,尽管它自1962年以来一直在开会。GRS成立于1996年,目的是为研究生和博士后提供一个论坛,参加与“上级”MIB GRC(一个晚上)重叠的会议,但也独立运行。这种组织结构确保了学生和博士后在发展自己的社区意识的同时与领先的研究人员互动,为该领域未来的领导者提供了一种出现的手段。为期两天半的GRS由年轻的研究人员在相关GRC的主要科学家的支持下组织。这两次会议的一个中心主题是需要了解金属离子在不同生物系统中发挥的关键作用。具体来说,金属离子对超过三分之一的酶的功能至关重要,并且参与了许多重要的生物合成途径,包括电化学到化学能的转化,以及抗生素、DNA、神经递质、类固醇、白三烯和激素的生物合成。关于金属酶功能的分子水平的细节出现在多个互补的研究线,在化学,生物学和物理学的界面。深入了解金属生物化学对于开发潜在的诊断工具和药物靶点来治疗诸如阿尔茨海默病、帕金森病和癌症等疾病至关重要。通过独特的戈登研究会议形式,在正式讲座和非正式互动中讨论这些问题,有效地传播了该领域研究前沿的发现知识,促进了合作,并提高了该领域的凝聚力,尽管它具有高度的多学科性质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM B Tolman其他文献
WILLIAM B Tolman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM B Tolman', 18)}}的其他基金
2011-2013 Metals in Biology GRC and Bioinorganic GRS
2011-2013 生物GRC和生物无机GRS中的金属
- 批准号:
8197758 - 财政年份:2010
- 资助金额:
$ 0.4万 - 项目类别:
2011-2013 Metals in Biology GRC and Bioinorganic GRS
2011-2013 生物GRC和生物无机GRS中的金属
- 批准号:
8045631 - 财政年份:2010
- 资助金额:
$ 0.4万 - 项目类别:
Synthetic Modeling of Copper Protein Active Sites
铜蛋白活性位点的综合建模
- 批准号:
10217146 - 财政年份:1992
- 资助金额:
$ 0.4万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 0.4万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 0.4万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 0.4万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 0.4万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 0.4万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 0.4万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 0.4万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 0.4万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 0.4万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 0.4万 - 项目类别: